Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1983-05-06
1986-07-29
Warren, Charles F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514563, 514617, 514622, 514824, 560 36, 562441, 564174, 564181, A61K 3122, A61K 31165, C07C10384, C07C10378
Patent
active
046031456
ABSTRACT:
This disclosure describes novel diaryl-alkanamides. These compounds are useful as pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial wall of mammals.
REFERENCES:
patent: 3296305 (1967-01-01), Doering et al.
patent: 3346634 (1967-10-01), Christensen et al.
patent: 3361790 (1968-01-01), Allen et al.
patent: 3736347 (1973-05-01), Billett et al.
patent: 3895057 (1975-07-01), Kaneko et al.
patent: 4392884 (1983-07-01), Pallos et al.
Miyamoto et al, Tetrahedron Letters, No. 25, pp. 2155-2156, 1978.
Work et al, CA 60:10590c.
Troxler, CA 71:13032c.
Popandova, CA 80:95438n.
Chemical Abstracts: Vol. 36, 1604(9); vol. 50, 4059(c); vol. 51, 15465 (a).
DeVries Vern G.
Shepherd Robert G.
Upeslacis Janis
American Cyanamid Company
Conroy, Jr. Edward A.
Greason C. S.
Warren Charles F.
LandOfFree
Antiatherosclerotic diphenyl alkanamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiatherosclerotic diphenyl alkanamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiatherosclerotic diphenyl alkanamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-700087